Dongshin to set 200 BW sales target by 2008.

Published: 2006-06-01 07:00:00

Updated: 2006-06-01 07:00:00

Dongshin pharmaceutical company announced on May 25 the sales forecast at 200 BW by 2008 from 138BW in 2006 to 165 BW in 2007 along with the ordinary incomes at 13 BW in 2006, 18.9 BW in 2007 and 24.3 BW in 2008.

To achieve this target, the company is going to explore overseas markets with the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK